Health Condition 1: L669- Cicatricial alopecia, unspecified
Conditions
Interventions
None listed
Sponsors
Indian association of dermatologist venereologist and leprologist
Eligibility
Inclusion criteria
Inclusion criteria: All cases of acquired cicatricial alopecia affecting any body part will be included who are willing to sign informed consent form, in case of minor, parent will have to sign informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients who are not willing to sign informed consent form 2. Patients with non scarring alopecia 3. Patients with traumatic cicatricial alopecia (Mechanical injury, Thermal injury, Electrical burns, Traction alopecia (persistent), Trichotillomania (persistent), Factitious injury, etc ) 4. Patients with congenital cicatricial alopecia (Aplasia cutis, Focal dermal hypoplasia, Dystrophic epidermolysis bullosa, Incontinentia pigmenti, Conradi syndrome, Keratosis pilaris atrophicans faciei, Keratosis follicularis spinulosa decalvans, Darierâ??s disease, Porokeratosis of Mibelli, Epidermal nevus, Lamellar ichthyosis, Marieâ??Unna syndrome, Follicular hamartoma syndrome, Polyostotic fibrous dysplasia, Hallermannâ??Streiff syndrome, Incontinentia pigmenti, Rappâ??Hodgkin syndrome) 5. Patients with secondary cicatricial alopecia due to infections. 6. Patients with soft tissue and appendageal tumours which might affect expression of CD34. 7. Patients with haematological disorders and malignancy. 8. Cutaneous malignancy involving head and neck. 9. Patients with vascular tumours 10.Malignancy induced primary or secondary cicatricial alopecia except Alopecia Mucinosa 11.Patients with history of previous scalp procedure 12.Patients with hypertrophic scars or keloid in head and neck area except acne keloidalis nuchae 13.Pregnant and lactating females
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To estimate the correlation between clinical, trichoscopic and histopathological findings and immunohistochemistry expression of hair follicle stem cell marker CD34 with duration of disease in patients of cicatricial alopecia.Timepoint: It is a cross sectional single visit study on day 0. | — |
Secondary
| Measure | Time frame |
|---|---|
| To estimate hospital-based prevalence of cicatricial alopecia. â?? To estimate correlation between clinical, trichoscopic and histopathological parameters in end stage cicatricial alopecia where there are no symptoms and histopathology reveals no inflammation.Timepoint: It is a cross sectional single visit study on day 0. | — |
Countries
India
Contacts
Public ContactDr Megha Lakum
GCS medical college hospital and research center
Outcome results
None listed